BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Brien M, Manches O, Bhardwaj N. Plasmacytoid dendritic cells in HIV infection. Adv Exp Med Biol 2013;762:71-107. [PMID: 22975872 DOI: 10.1007/978-1-4614-4433-6_3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Leymarie O, Lepont L, Berlioz-Torrent C. Canonical and Non-Canonical Autophagy in HIV-1 Replication Cycle. Viruses 2017;9:E270. [PMID: 28946621 DOI: 10.3390/v9100270] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
2 Barrat FJ, Su L. A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection. J Exp Med 2019;216:1974-85. [PMID: 31420375 DOI: 10.1084/jem.20181359] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
3 Kazer SW, Aicher TP, Muema DM, Carroll SL, Ordovas-Montanes J, Miao VN, Tu AA, Ziegler CGK, Nyquist SK, Wong EB, Ismail N, Dong M, Moodley A, Berger B, Love JC, Dong KL, Leslie A, Ndhlovu ZM, Ndung'u T, Walker BD, Shalek AK. Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection. Nat Med 2020;26:511-8. [PMID: 32251406 DOI: 10.1038/s41591-020-0799-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
4 Wilhelm TR, Taddeo A, Winter O, Schulz AR, Mälzer JN, Domingo C, Biesen R, Alexander T, Thiel A, Radbruch A, Hiepe F, Gerl V. Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses. Clin Immunol 2016;163:42-51. [PMID: 26674280 DOI: 10.1016/j.clim.2015.12.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
5 Echebli N, Tchitchek N, Dupuy S, Bruel T, Peireira Bittencourt Passaes C, Bosquet N, Le Grand R, Bourgeois C, Favier B, Cheynier R, Lambotte O, Vaslin B. Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection. PLoS One 2018;13:e0190334. [PMID: 29324751 DOI: 10.1371/journal.pone.0190334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Konadu KA, Anderson JS, Huang MB, Ali SA, Powell MD, Villinger F, Bond VC. Hallmarks of HIV-1 pathogenesis are modulated by Nef's Secretion Modification Region. J AIDS Clin Res 2015;6:476. [PMID: 26523240 DOI: 10.4172/2155-6113.1000476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Su B, Lederle A, Laumond G, Ducloy C, Schmidt S, Decoville T, Moog C. Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes. J Virol 2014;88:10975-81. [PMID: 24965460 DOI: 10.1128/JVI.01748-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
8 Camacho-Sandoval R, Del Río Estrada PM, Rivero-Arrieta A, Reyes-Terán G, Bonifaz LC. Differential partial activation phenotype and production of tumour necrosis factor-α by conventional dendritic cells in response to lipopolysaccharide in HIV+ viraemic subjects and HIV+ controllers. Clin Exp Immunol 2014;178:489-503. [PMID: 25130456 DOI: 10.1111/cei.12430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Konadu KA, Huang MB, Roth W, Armstrong W, Powell M, Villinger F, Bond V. Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals. J Vis Exp 2016. [PMID: 26780239 DOI: 10.3791/53495] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
10 Nguyen NV, Tran JT, Sanchez DJ. HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation. Innate Immun 2018;24:490-500. [PMID: 30282499 DOI: 10.1177/1753425918803674] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ali S, Mann-Nüttel R, Schulze A, Richter L, Alferink J, Scheu S. Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat. Front Immunol 2019;10:778. [PMID: 31031767 DOI: 10.3389/fimmu.2019.00778] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 20.5] [Reference Citation Analysis]
12 Kim H, Zhang W, Hwang J, An EK, Choi YK, Moon E, Loznik M, Huh YH, Herrmann A, Kwak M, Jin JO. Carrier-free micellar CpG interacting with cell membrane for enhanced immunological treatment of HIV-1. Biomaterials 2021;277:121081. [PMID: 34481291 DOI: 10.1016/j.biomaterials.2021.121081] [Reference Citation Analysis]
13 Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015;15:471-485. [PMID: 26160613 DOI: 10.1038/nri3865] [Cited by in Crossref: 551] [Cited by in F6Publishing: 535] [Article Influence: 91.8] [Reference Citation Analysis]
14 McCauley SM, Kim K, Nowosielska A, Dauphin A, Yurkovetskiy L, Diehl WE, Luban J. Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines. Nat Commun 2018;9:5305. [PMID: 30546110 DOI: 10.1038/s41467-018-07753-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
15 Lederle A, Su B, Holl V, Penichon J, Schmidt S, Decoville T, Laumond G, Moog C. Neutralizing antibodies inhibit HIV-1 infection of plasmacytoid dendritic cells by an FcγRIIa independent mechanism and do not diminish cytokines production. Sci Rep 2014;4:5845. [PMID: 25132382 DOI: 10.1038/srep05845] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
16 Soltani S, Mahmoudi M, Farhadi E. Dendritic Cells Currently under the Spotlight; Classification and Subset Based upon New Markers. Immunol Invest 2021;50:646-61. [PMID: 32597286 DOI: 10.1080/08820139.2020.1783289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Panda SK, Kolbeck R, Sanjuan MA. Plasmacytoid dendritic cells in autoimmunity. Curr Opin Immunol 2017;44:20-5. [PMID: 27855321 DOI: 10.1016/j.coi.2016.10.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
18 Sugawara S, Thomas DL, Balagopal A. HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters. AIDS Res Hum Retroviruses 2019;35:25-32. [PMID: 29999412 DOI: 10.1089/AID.2018.0161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
19 Dillon SM, Lee EJ, Kotter CV, Austin GL, Gianella S, Siewe B, Smith DM, Landay AL, McManus MC, Robertson CE, Frank DN, McCarter MD, Wilson CC. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol 2016;9:24-37. [PMID: 25921339 DOI: 10.1038/mi.2015.33] [Cited by in Crossref: 107] [Cited by in F6Publishing: 109] [Article Influence: 17.8] [Reference Citation Analysis]
20 Bencze D, Fekete T, Pázmándi K. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control. Int J Mol Sci 2021;22:4190. [PMID: 33919546 DOI: 10.3390/ijms22084190] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Zhang LL, Zhang ZN, Wu X, Jiang YJ, Fu YJ, Shang H. Transcriptomic meta-analysis identifies gene expression characteristics in various samples of HIV-infected patients with nonprogressive disease. J Transl Med 2017;15:191. [PMID: 28899396 DOI: 10.1186/s12967-017-1294-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Martín-Moreno A, Muñoz-Fernández MA. Dendritic Cells, the Double Agent in the War Against HIV-1. Front Immunol 2019;10:2485. [PMID: 31708924 DOI: 10.3389/fimmu.2019.02485] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
23 Acchioni C, Marsili G, Perrotti E, Remoli AL, Sgarbanti M, Battistini A. Type I IFN--a blunt spear in fighting HIV-1 infection. Cytokine Growth Factor Rev 2015;26:143-58. [PMID: 25466629 DOI: 10.1016/j.cytogfr.2014.10.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
24 Vidya Vijayan KK, Karthigeyan KP, Tripathi SP, Hanna LE. Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections. Front Immunol 2017;8:580. [PMID: 28588579 DOI: 10.3389/fimmu.2017.00580] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
25 Bosinger SE, Utay NS. Type I interferon: understanding its role in HIV pathogenesis and therapy. Curr HIV/AIDS Rep 2015;12:41-53. [PMID: 25662992 DOI: 10.1007/s11904-014-0244-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 11.2] [Reference Citation Analysis]
26 Pham TNQ, Meziane O, Miah MA, Volodina O, Colas C, Béland K, Li Y, Dallaire F, Keler T, Guimond JV, Lesage S, Cheong C, Haddad É, Cohen ÉA. Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized Mice. Cell Rep 2019;29:2770-2782.e5. [PMID: 31775044 DOI: 10.1016/j.celrep.2019.10.094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
27 Chitre AS, Kattah MG, Rosli YY, Pao M, Deswal M, Deeks SG, Hunt PW, Abdel-Mohsen M, Montaner LJ, Kim CC, Ma A, Somsouk M, McCune JM. A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function. PLoS Pathog 2018;14:e1006806. [PMID: 29505600 DOI: 10.1371/journal.ppat.1006806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Crow MK, Ronnblom L. Type I interferons in host defence and inflammatory diseases. Lupus Sci Med 2019;6:e000336. [PMID: 31205729 DOI: 10.1136/lupus-2019-000336] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 21.5] [Reference Citation Analysis]
29 Angin M, Klarenbeek PL, King M, Sharma SM, Moodley ES, Rezai A, Piechocka-Trocha A, Toth I, Chan AT, Goulder PJ. Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity. PLoS One. 2014;9:e86920. [PMID: 24498287 DOI: 10.1371/journal.pone.0086920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
30 Khowawisetsut L, Pattanapanyasat K, Onlamoon N, Mayne AE, Little DM, Villinger F, Ansari AA. Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques. PLoS One 2013;8:e61264. [PMID: 23620737 DOI: 10.1371/journal.pone.0061264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
31 Agrati C, De Biasi S, Fidanza L, Gibellini L, Nasi M, Pinti M, Cossarizza A. The importance of advanced cytometry in defining new immune cell types and functions relevant for the immunopathogenesis of HIV infection. AIDS 2020;34:2169-85. [PMID: 32910071 DOI: 10.1097/QAD.0000000000002675] [Reference Citation Analysis]
32 Maldonado S, Fitzgerald-Bocarsly P. Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection. Front Immunol 2017;8:1705. [PMID: 29255464 DOI: 10.3389/fimmu.2017.01705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
33 Kazer SW, Walker BD, Shalek AK. Evolution and Diversity of Immune Responses during Acute HIV Infection. Immunity 2020;53:908-24. [PMID: 33207216 DOI: 10.1016/j.immuni.2020.10.015] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Akiyama H, Ramirez NP, Gibson G, Kline C, Watkins S, Ambrose Z, Gummuluru S. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon. J Virol 2017;91:e00972-17. [PMID: 28794041 DOI: 10.1128/JVI.00972-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
35 Smith N, Pietrancosta N, Herbeuval JP. [CXCR4, master regulator of innate immune responses?]. Med Sci (Paris) 2017;33:711-3. [PMID: 28945553 DOI: 10.1051/medsci/20173308008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Geginat J, Nizzoli G, Paroni M, Maglie S, Larghi P, Pascolo S, Abrignani S. Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets. Front Immunol 2015;6:527. [PMID: 26528289 DOI: 10.3389/fimmu.2015.00527] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
37 Griesbeck M, Valantin MA, Lacombe K, Samri-Hassimi A, Bottero J, Blanc C, Sbihi Z, Zoorob R, Katlama C, Guiguet M, Altfeld M, Autran B; HepACT-VIH study group. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals. AIDS 2017;31:1223-34. [PMID: 28492391 DOI: 10.1097/QAD.0000000000001455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Aiello A, Giannessi F, Percario ZA, Affabris E. The involvement of plasmacytoid cells in HIV infection and pathogenesis. Cytokine Growth Factor Rev 2018;40:77-89. [PMID: 29588163 DOI: 10.1016/j.cytogfr.2018.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
39 Ambada GN, Ntsama CE, Nji NN, Ngu LN, Sake CN, Lissom A, Tchouangeu FT, Tchadji J, Sosso M, Etoa FX, Nchinda GW. Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people. Immunology 2017;151:405-16. [PMID: 28375551 DOI: 10.1111/imm.12738] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
40 Davidson S, Maini MK, Wack A. Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res. 2015;35:252-264. [PMID: 25714109 DOI: 10.1089/jir.2014.0227] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 17.2] [Reference Citation Analysis]
41 Soper A, Kimura I, Nagaoka S, Konno Y, Yamamoto K, Koyanagi Y, Sato K. Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control. Front Immunol 2017;8:1823. [PMID: 29379496 DOI: 10.3389/fimmu.2017.01823] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
42 Wolf G, Singh NJ. Modular Approaches to Understand the Immunobiology of Human Immunodeficiency Virus Latency. Viral Immunol 2021;34:365-75. [PMID: 33600238 DOI: 10.1089/vim.2020.0171] [Reference Citation Analysis]
43 Alqudah MA, Yaseen MM, Yaseen MM. HIV-1 strategies to overcome the immune system by evading and invading innate immune system. HIV & AIDS Review 2016;15:1-12. [DOI: 10.1016/j.hivar.2015.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
44 Dewald HK, Hurley HJ, Fitzgerald-Bocarsly P. Regulation of Transcription Factor E2-2 in Human Plasmacytoid Dendritic Cells by Monocyte-Derived TNFα. Viruses 2020;12:E162. [PMID: 32023836 DOI: 10.3390/v12020162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Cohn LB, Deeks SG. The immune response fails to control HIV early in initial virus spread. J Clin Invest 2020;130:2803-5. [PMID: 32338639 DOI: 10.1172/JCI136886] [Reference Citation Analysis]